Pacific Biosciences Of California (PACB) Sales of Property, Plant and Equipment (2015 - 2026)

Pacific Biosciences Of California (PACB) Sales of Property, Plant and Equipment (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 3.51 Mn
10 Pacific Biosciences Of California 415.91 Mn 139.95 Mn 12.84 Mn 50.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 50.00 Mn
Mar 31, 2026 50.00 Mn
Dec 31, 2017 39,000.00
Dec 31, 2017 39,000.00
Sep 30, 2017 -10,000.00
Sep 30, 2017 -10,000.00
Jun 30, 2016 -101,000.00
Jun 30, 2016 -101,000.00
Mar 31, 2016 111,000.00
Mar 31, 2016 111,000.00
Dec 31, 2015 24,000.00
Dec 31, 2015 24,000.00
Sep 30, 2015 6,000.00
Sep 30, 2015 6,000.00